| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |